Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer
(Q73690540)
scientific article published on 01 September 1997
scientific article published on 01 September 1997
Language:
Current Data About
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer
other details
description | scientific article published on 01 September 1997 |
External Links
(P356) |
10.1200/JCO.1997.15.9.3156
|
(P698) |
9294479
|